Salmeterol is a competitive antagonist at β-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils
- 9 February 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 231 (2) , 305-308
- https://doi.org/10.1016/0014-2999(93)90466-u
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Formoterol, fenoterol, and salbutamol as partial agonists for relaxation of maximally contracted guinea pig tracheae: Comparison of relaxation with receptor bindingLung, 1992
- Estimation of the efficacy and affinity of the β2‐adrenoceptor agonist salmeterol in guinea‐pig tracheaBritish Journal of Pharmacology, 1991
- Salmeterol: a potent and long‐acting inhibitor of inflammatory mediator release from human lungBritish Journal of Pharmacology, 1991
- Salmeterol, a novel, long‐acting β2‐adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivoBritish Journal of Pharmacology, 1991
- Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan‐stimulated respiratory burst by ‘type IV’‐selective PDE inhibitorsBritish Journal of Pharmacology, 1991
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990
- Beta2-Adrenergic Receptors on Eosinophils: Binding and Functional StudiesAmerican Review of Respiratory Disease, 1990
- Transient Catecholamine Modulation of Neutrophil Activation: Kinetic and Intracellular Aspects of Isoproterenol ActionJournal of Leukocyte Biology, 1986